NuSkin Enterprises, Inc. (NUS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NUS trades at $5.84 with a market cap of $284.51M and a P/E ratio of 5.18. NUS moved +2.46% today. Year to date, NUS is -39.73%; over the trailing twelve months it is -23.06%. Its 52-week range spans $5.32 to $14.62. Rallies surfaces NUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded NUS stock?
Rallies tracks politician and congressional stock disclosures for NUS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Nathanson Laura sold 2.68K (~$18.01K) on May 11, 2026.
Hatchett Steven Keith bought 5.50K (~$52.85K) on Nov 11, 2025.
Nathanson Laura sold 6.49K (~$79.30K) on Sep 4, 2025.
NUS Analyst Consensus
NUS analyst coverage data. Average price target: $0.00.
Common questions about NUS
Which politicians traded NUS stock?
Rallies tracks politician and congressional stock disclosures for NUS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in NUS?
Yes. Rallies tracks politician and congressional stock disclosures for NUS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is NUS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NUS. It does not provide personalized investment advice.
